Monte Carlo Method Based QSAR Studies of Mer Kinase Inhibitors in Compliance with OECD Principles

Parvin Kumar; Ashwani Kumar

doi:10.1055/s-0043-119288

Drug Research, Inhaltsverzeichnis

Drug Res (Stuttg) 2018; 68(04): 189-195
DOI: 10.1055/s-0043-119288

Original Article

Monte Carlo Method Based QSAR Studies of Mer Kinase Inhibitors in Compliance with OECD Principles

Parvin Kumar

¹Department of Chemistry, Kurukshetra University, Kurukshetra, Haryana, India

,

Ashwani Kumar

²Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India

› Institutsangaben

Abstract

Monte Carlo method based QSAR studies for inhibitors of Mer kinase, a potential novel target for cancer treatment, has been carried out using balance of correlation technique. The data was divided into three random and dissimilar splits and hybrid optimal descriptors derived from SMILES and hydrogen filled graphs based notations were used for construction of QSAR models. The generated models have good fitting ability, robustness, generalizability and internal predictive ability. The external predictive ability has been tested using multiple criteria and described models exhibited good performance in all of these tests. The values of R², Q², R² _test, Q² _test, R² _m and ∆R² _m for the best model are 0.9502, 0.9388, 0.9469, 0.9083, 0.7534 and 0.0894 respectively. Also, the structural characteristics responsible for enhancement and reduction of activity have been extracted. Further, the agreement with the OECD rules for QSAR model has been discussed.

Key words

Mer kinase - QSAR - CORAL - SMILES - OECD

Volltext

Referenzen

References
1 Benigni R. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?. Expert Opin Drug Met 2012; 8: 407-417
2 Mor S, Nagoria S, Kumar A. et al. QSAR studies and design of some tetracyclic 1,4-benzothiazines as antimicrobial agents. Drug Res (Stuttg) 2016; 66: 436-443
3 Toropov AA, Toropova AP. CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. Eur J Pharm Sci 2014; 52: 21-25
4 Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci 2007; 26: 694-701
5 Veselinović AM, Veselinović JB, Živković JV. et al. Application of smiles notation based optimal descriptors in drug discovery and design. Curr Top Med Chem 2015; 15: 1768-1779
6 Toropov AA, Toropova AP, Benfenati E. et al. CORAL: classification model for predictions of anti-sarcoma activity. Curr Top Med Chem 2012; 12: 2741-2744
7 Toropov AA, Toropova AP, Pizzo F. et al. CORAL: model for no observed adverse effect level (NOAEL). Mol Divers 2015; 19: 563-575
8 Kumar A, Chauhan S. QSAR diﬀerential model for prediction of SIRT1 modulation using monte carlo method. Drug Res (Stuttg). 2017; 67: 156-162
9 Kumar A, Chauhan S. Use of the Monte Carlo method for OECD principles-guided QSAR modeling of SIRT1 inhibitors. Arch Pharm Chem Life Sci 2017; 350: e1600268
10 Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C. et al. QSAR study of H1N1 neuraminidase inhibitors from inﬂuenza A virus. Lett Drug Des Discov 2014; 11: 420-427
11 Martinez JCG, Duchowicz PR, Estrada MR. et al. QSAR study and molecular design of open-chain enaminones as anticonvulsant agents. Int J Mol Sci 2011; 12: 9354-9368
12 Masand VH, Toropov AA, Toropova AP. et al. QSAR models for antimalarial activity of 4-aminoquinolines. Curr Comput Aided Drug Des 2014; 10: 75-82
13 Toropova AP, Toropov AA, Veselinovic JB. et al. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method. Eur J Med Chem 2014; 77: 298-305
14 Toropov AA, Toropova AP, Benfenati E. et al. QSAR models for inhibitors of physiological impact of Escherichia coli that leads to diarrhea. Biochem Biophys Res Commun 2013; 432: 214-225
15 Mullen LMA, Duchowicz PR, Castro EA. QSAR treatment on a new class of triphenylmethyl-containing compounds as potent anticancer agents. Chemometr Intell Lab Syst 2011; 107: 269-275
16 Worachartcheewan A, Mandi P, Prachayasittikul V. et al. Large-scale QSAR study of aromatase inhibitors using SMILES-based descriptors. Chemometr Intell Lab Syst 2014; 138: 120-126
17 García J, Duchowicz PR, Rozas MF. et al. A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. J Mol Graph Model 2011; 31: 10-19
18 Sokolović D, Stanković V, Toskić D. et al. Monte Carlo-based QSAR modeling of dimeric pyridinium compounds and drug design of new potent acetylcholine esterase inhibitors for potential therapy of myasthenia gravis. Struct Chem 2016; 27: 1511-1519
19 Sokolović D, Aleksić D, Milenković V. et al. QSAR modeling of bis-quinolinium and bis-isoquinolinium compounds as acetylcholine esterase inhibitors based on the Monte Carlo method—the implication for Myasthenia gravis treatment. Med Chem Res 2016; 25: 2989-2998
20 Sokolović D, Ranković J, Stanković V. et al. QSAR study of dipeptidyl peptidase-4 inhibitors based on the Monte Carlo method. Med Chem Res 2017; 26: 796-804
21 Živković JV, Trutić NV, Veselinović JB. et al. Monte Carlo method based QSAR modeling of maleimide derivatives as glycogen synthase kinase-3β inhibitors. Comput Biol Med 2015; 64: 276-282
22 Kumar A, Chauhan S. Monte Carlo method based QSAR modelling of natural lipase inhibitors using hybrid optimal descriptors. SAR QSAR Environ Res 2017; 28: 179-197
23 Linger RMA, Keating AK, Earp HS. et al Advances in Cancer Research. Academic Press; New York: 2008
24 Chen CL, Li Q, Darrow AL. et al. Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler Thromb Vasc Biol 2004; 24: 1118-1123
25 Laurance S, Lemarie CA, Blostein MD. Growth Arrest-Specific Gene 6 (gas6) and Vascular Hemostasis. Adv Nutr 2012; 3 (02) 196-203
26 Yu Z, Li X, Ge C. et al. 3D-QSAR modeling and molecular docking study on Mer kinase inhibitors of pyridine-substituted pyrimidines. Mol Divers 2015; 19: 135-147
27 Marvin Sketch 5.10.1 Chem Axon Ltd. 1998–2012 http://www.chemaxon.com
28 O’Boyle N, Banck M, James CA. et al. Open Babel: An open chemical toolbox. J Chem Inf 2011; 3: 33
29 Toropov AA, Toropova AP, Benfenati E. et al. The definition of the molecular structure for potential anti-malaria agents by the Monte Carlo method. Struct Chem 2013; 24: 1369-1381
30 Toropova AP, Toropov AA, Benfenati E. et al. CORAL: quantitative structure–activity relationship models for estimating toxicity of organic compounds in rats. J Comput Chem 2011; 32: 2727-2733
31 Ojha PK, Roy K. Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection. Chemometr Intell Lab 2011; 109: 146-161
32 Golbraikh A, Tropsha A. Beware of q2!. J Mol Graph Model 2002; 20: 269-276
33 Roy PP, Roy K. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors. Chem Biol Drug Des 2009; 73: 442-455
34 Ojha PK, Mitra I, Das RN. et al. Further exploring r² _m metrics for validation of QSPR models. Chemometr Intell Lab Syst 2011; 107: 194-205
35 Toropov AA, Toropova AP. The index of ideality of correlation: A criterion of predictive potential of QSPR/QSAR models?. Mutation Research – Genetic Toxicology and Environmental Mutagenesis 2017; 819: 31-37
36 Toropova AP, Toropov AA. The index of ideality of correlation: A criterion of predictability of QSAR models for skin permeability?. Science of the Total Environment 2017; 586: 466-472

Zusatzmaterial

Supporting Information